Cellosaurus logo
expasy logo

Cellosaurus AR230-rn (CVCL_DP53)

[Text version]
Cell line name AR230-rn
Accession CVCL_DP53
Resource Identification Initiative To cite this cell line use: AR230-rn (RRID:CVCL_DP53)
Comments Population: Japanese.
Selected for resistance to: ChEBI; CHEBI_52172; Nilotinib (AMN107; Tasigna).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=Mu-BCR transcript (from parent cell line).
Disease Chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C3174)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_9478 (AR230)
Sex of cell Female
Age at sampling 52Y
Category Cancer cell line
Publications

PubMed=19047160; DOI=10.1158/0008-5472.CAN-08-1008
Mahon F.-X., Hayette S., Lagarde V., Belloc F., Turcq B., Nicolini F., Belanger C., Manley P.W., Leroy C., Etienne G., Roche S., Pasquet J.-M.
Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.
Cancer Res. 68:9809-9816(2008)

Cross-references
Encyclopedic resources Wikidata; Q54750358
Entry history
Entry creation13-Jul-2016
Last entry update19-Dec-2024
Version number11